<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02943772</url>
  </required_header>
  <id_info>
    <org_study_id>0092-16-KMC</org_study_id>
    <nct_id>NCT02943772</nct_id>
  </id_info>
  <brief_title>Does Local Cooling of Testis in Patients With Epididymitis Relieve Pain and Reduce Quantity of Analgetics Intake?</brief_title>
  <official_title>Effect of Local Cooling of Testis in Patient With Epididymitis on Analgetics Consumption and Pain Level</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaplan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaplan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to examine the effect of local cooling of testis in participants
      with acute epididymitis or orchiepididymitis on participants reported pain level and
      analgetics consumption.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epididymitis or orchiepididymitis is an acute disease causing pain and discomfort.

      our hypothesis is that local cooling of the affected testis or epididymis may relieve the
      pain and reduce the analgetics consumption In order to examine this hypothesis we will
      recruit adult patients with epididymitis or orchiepididymitis and will randomize these
      patients to two arms.

      One arm will receive every 8 hours a brick cooled for at least 2 hours in -20(celsius) for
      local use on the affected hemiscrotum, while the second arm will receive a brick in room
      temperature.

      Pain level will be estimated one hour following the application of the brick using visual
      analogue pain score. Patient will receive analgetics according to a predefined escalating
      protocol.

      Pain level and analgetics consumption will be compared between the two arms.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in pain level</measure>
    <time_frame>pain level change from baseline three times a day following the intervention of brick/cooled brick from randomization throughout the hospitalization for at least 24 hours of hospitalization and up to 50weeks</time_frame>
    <description>intervention and measurement will be examined three times a day following brick/cooled brick</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total consumption in grams of protocol analgetics</measure>
    <time_frame>analgetics consumption will be recorded from randomization throughout the hospitalization for at least 24 hours of hospitalization and up to 50weeks</time_frame>
    <description>each protocol Analgetic will be summarized individually in grams</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Local hypothermia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Local application of a brick cooled to -20(celsius)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Local application of a brick in room temperature</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Local hypothermia</intervention_name>
    <description>Cooled brick</description>
    <arm_group_label>Local hypothermia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Control brick</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male patients 18-99 years

          -  Acute epididymitis or acute orchiepididymitis

        Exclusion Criteria:

          -  Patient unable to informed consent

          -  Suspicion of testicular malignancy
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan Leibovici, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kapaln medical center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Igal Shpunt, MD</last_name>
    <phone>+972-8-944-1642</phone>
    <email>igal2k@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yuval Avda, MD</last_name>
    <phone>+972-8-944-1516</phone>
    <email>yuvalab@clalit.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kaplan Medical Center</name>
      <address>
        <city>Rehovot</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>igal shpunt, MD</last_name>
      <phone>972545857588</phone>
      <email>igal2k@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Uri lindner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dan Leibovici, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>yuval avda, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2016</study_first_submitted>
  <study_first_submitted_qc>October 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2016</study_first_posted>
  <last_update_submitted>October 22, 2016</last_update_submitted>
  <last_update_submitted_qc>October 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kaplan Medical Center</investigator_affiliation>
    <investigator_full_name>Dan Leibovici</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epididymitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

